Physician profile
Kevin S Berman
NPI 1134426539
$3,915.85
in general payments reported to CMS, 2019-2025
14 companies · $68.96 in 2025
The $68.96 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $45.53 · 2021: $256 · 2022: $2,335 · 2023: $332 · 2024: $16.23 · 2025: $68.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $229 · Food and Beverage: $137 · Long Term Medical Supply Or Device Loan: $50.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $229.42 |
| Food and Beverage | $137.40 |
| Long Term Medical Supply Or Device Loan | $50.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,728.11 | 2021-2022 | |
| Davol INC. | $916.81 | 2019-2023 | Phasix Mesh |
| Kci USA, INC. | $773.58 | 2019 | |
| Smith+Nephew, INC. | $249.77 | 2019-2023 | Acticoat 4" X 4", Allevyn Life L 15.4x15.4 Ctn10, Renasys Go V2 Home |
| Pentax of America, INC. | $50.50 | 2025 | Scaleor |
| Medtronic, INC. | $46.63 | 2022-2023 | Absorbatack |
| Orthofix Medical, INC. | $22.18 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.50 | 2023 | |
| Baudax Bio INC. | $21.48 | 2022 | |
| Ethicon US, LLC | $19.23 | 2019 | |
| Janssen Biotech, INC. | $18.46 | 2025 | Tremfya |
| Ardelyx, INC. | $16.23 | 2024 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $15.91 | 2023 | Entyvio |
| Kerecis Limited | $15.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.